U.S. Gas Utilities Stock News

Axsome Therapeutics reported that the FDA has accepted its New Drug Application for AXS-12 for the treatment of cataplexy in narcolepsy. The FDA does not plan to hold an advisory committee meeting as part of the review. The filing acceptance marks a key regulatory step for AXS-12, a potential option for a serious sleep disorder with unmet medical need. For Axsome Therapeutics (NasdaqGM:AXSM), this regulatory milestone arrives with the stock trading around $239.62 and a very large 3 year and...

United Rentals stock has delivered a strong 229.4% return over the past five years, yet its valuation checks are sending mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples lean the other way. For investors trying to assess what the current US$1,035.06 share price really reflects, the split between these frameworks is central. Over five years United Rentals has returned 229.4%, which puts extra focus on whether recent...

With inflation, energy prices and interest rate expectations all pulling markets in different directions, many investors are looking for leaders whose interests are closely tied to long term outcomes rather than short term headlines. Founder led companies can fit that brief, as founders often have more of their own wealth, reputation and time invested in the business. This article looks at a curated Founder Led Companies screener that focuses on leaders who are personally committed to...

Houlihan Lokey stock has delivered a 76.5% total return over the past five years, yet its current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples suggest the shares trade at a richer level. Over five years, a 76.5% return suggests Houlihan Lokey has rewarded patient shareholders, even though the share price has recently been under pressure. For a specialist advisory firm like Houlihan Lokey, expectations for...

Nu Holdings has delivered an 84.8% return over the past three years, yet its valuation signals are split, with an Excess Returns intrinsic value estimate suggesting about 11.1% upside while market multiples lean toward the stock looking expensive. Nu Holdings' 84.8% return over three years puts recent shareholders in a strong position. This raises the question of how much upside is left from here. Recent progress on full banking licenses in Brazil and Mexico can support expectations for...

RH stock has had a difficult run over the past few years, and the latest valuation work points to shares trading at a premium, with both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples indicating the stock screens as overvalued rather than as a clear bargain. RH has declined about 74.0% over the past five years, which means long term shareholders are still sitting on sizeable losses despite shorter term rebounds. Expectations for stronger earnings growth...

Vistra stock has delivered an extremely strong 5 year return, but after that run the valuation screens now point to something closer to a middle ground than a clear bargain or clear excess. Over the last 5 years, Vistra has returned about 8.4x an initial investment, which puts extra focus on whether the current price still reflects its fundamentals. Growing attention on power demand from data centers and AI infrastructure can support long term earnings expectations for Vistra, while...

Big Tech’s rush to issue AI-related debt is pouring hundreds of billions into the bond market, helping push long-term Treasury yields toward 5% and making risk free income look more appealing. That shift can weigh on share prices; yet it also shines a spotlight on high-yield dividend stocks with at least 3% yields, moderate risk scores, and manageable leverage. For investors who want income but are cautious about heavy borrowing costs, this screen surfaces companies that may handle higher...

Resignation of Asana’s Chief Accounting Officer Asana (ASAN) recently disclosed that Chief Accounting Officer and Principal Accounting Officer Veronica Sosa has resigned, with her departure effective August 7, 2026, following a transition period in her current role. The company stated that Sosa’s resignation did not arise from any disagreements with Asana regarding operations, policies, practices, or accounting matters, which may guide how investors interpret this leadership change. See our...

Waste Management (NYSE:WM) reported a strong 2025, highlighting growth in renewable natural gas and recycling. The company announced a 14.5% dividend increase for 2026. Waste Management also introduced a new US$3b share repurchase program. For investors watching the waste and recycling sector, Waste Management stands out as a large, vertically integrated operator with exposure to collection, landfill, recycling, and renewable natural gas. Recent company updates point to meaningful activity...

Many MapLight Therapeutics, Inc. ( NASDAQ:MPLT ) insiders ditched their stock over the past year, which may be of...

Over the last 7 days, the United States market has dropped 1.4%, yet it remains up 16% over the past year, with earnings anticipated to grow by 18% annually in the coming years. In this context, identifying stocks that might be trading below their estimated intrinsic values can offer investors potential opportunities for long-term growth amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 1.4% drop, yet it remains up by 16% over the past year, with earnings forecasted to grow by 18% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company and may align well with anticipated earnings growth.

Over the last 7 days, the market has dropped 1.4%, but it is up 16% over the past year, with earnings forecasted to grow by 18% annually. For investors willing to explore beyond well-known stocks, penny stocks—often smaller or newer companies—can be full of surprises and remain a relevant investment area despite being a somewhat outdated term. In this article, we highlight three penny stocks that stand out for their financial strength and potential for growth.

Avanos Medical (AVNS) continues to trade around $24.98, drawing attention from investors who are weighing its medical device portfolio against mixed financial metrics, including modest annual revenue growth and a reported net loss. See our latest analysis for Avanos Medical. Over the past year Avanos Medical’s share price return has moved sharply higher, with a year to date share price return of 123.43% and a 1 year total shareholder return of 106.28%. However, the 5 year total shareholder...

Alexander's (ALX) continues to draw attention after recent share price moves alongside its latest reported figures, including US$211.68 million in revenue and US$20.57 million in net income from its New York focused real estate portfolio. See our latest analysis for Alexander's. At a latest share price of US$276.53, Alexander's has seen a 26.35% year to date share price return and a 16.80% total shareholder return over the past year, with the recent 1 day decline of 3.35% tempering what has...

Small caps sit at the crossroads of several powerful forces right now, from a US equity market trading at an 8% discount to fair value to shifting views on inflation, interest rates, and credit risk. For investors willing to look beyond the largest technology and AI stocks, this mix of lower valuations and changing macro conditions can create both opportunities and traps. This article breaks down what the recent news on inflation, Federal Reserve policy, and credit markets could mean for...

Univest Financial has delivered strong share price gains over the past three years, yet there is a clear split between valuation frameworks. The Excess Returns intrinsic value estimate points to upside, while earnings-based multiples look relatively rich. Univest Financial has returned 133.1% over the past three years, which puts extra focus on whether the current price already reflects much of the good news. The valuation debate hinges on how durable the bank's profitability and credit...

Travel + Leisure (TNL) has just posted Q2 2026 results with revenue of US$1,063 million and basic EPS of US$1.75, alongside trailing twelve month revenue of US$4.1 billion and EPS of US$3.73 that give investors a broader read on the current earnings run rate. Over the last six reported quarters, revenue has ranged from US$934 million to US$1,063 million while quarterly basic EPS has moved between a loss of US$0.95 and a profit of US$1.75. This sets the stage for investors to weigh the latest...

IonQ stock has delivered a very strong 249.2% return over the past 5 years, yet its current valuation checks lean expensive and recent share price weakness raises questions about how much optimism is already in the price. IonQ has returned 249.2% over 5 years, which puts long term holders in a strong position but also raises the bar for what future fundamentals may need to support. Fresh research around using IonQ’s trapped ion systems to cut energy use in AI workloads can support long term...

Cal-Maine Foods (CALM) closed out FY 2026 with fourth quarter revenue of US$552.6 million and a quarterly loss of US$35.9 million, or EPS of US$0.76, against a backdrop of trailing 12 month EPS of US$6.65 on revenue of US$2.9 billion. Over recent quarters, the company has seen revenue move from US$1.4 billion in Q3 FY 2025 and EPS of US$10.42 to US$922.6 million and EPS of US$4.13 in Q1 FY 2026, before landing at the latest reported levels. With trailing net profit margin now sitting at 10.9%...

Pegasystems (PEGA) has reported Q2 2026 revenue of US$420.7 million with basic EPS of US$0.08, alongside trailing 12 month revenue of about US$1.74 billion and basic EPS of US$1.92 that sit against a 47.2% earnings growth rate over the past year. Over recent quarters the company has seen revenue range between US$381.4 million and US$504.3 million, while quarterly EPS has moved between US$0.18 and US$1.38. This sets up the latest print against a period of rising trailing net margins from 13.1%...

East West Bancorp (EWBC) opened Q2 2026 with total revenue of US$735.3 million and basic EPS of US$2.65, supported by net income of US$363.7 million. The company reported revenue of US$632.0 million and EPS of US$2.25 in Q2 2025, compared with US$735.3 million and EPS of US$2.65 in Q2 2026. Trailing 12 month EPS stands at US$10.46 on revenue of US$2.89 billion. These figures provide a basis for investors to examine how the company’s net interest margin and cost efficiency affect the...

Metropolitan Bank Holding (MCB) has just posted Q2 2026 results with revenue of US$79.7 million and basic EPS of US$1.55, alongside trailing twelve month revenue of US$312.0 million and EPS of US$7.98. Over recent quarters, revenue has moved from US$69.9 million in Q2 2025 to US$85.6 million in Q4 2025 and US$90.8 million in Q1 2026 before this latest print. Quarterly EPS has ranged from US$0.68 in Q3 2025 to US$2.94 in Q1 2026, which puts the focus on how efficiently those earnings are being...